In-Med Prognostics

Neurophet logo
By  Adam Ang 01:49 am November 17, 2023
Neurophet scores $15M in Series C funding, announces 2024 IPO South Korean company Neurophet, a provider of brain image analysis software, has raised 20 billion won ($15 million) in a Series C funding round participated by institutional investors, such as KB Securities, Mirae Asset Securities, and IBK Industrial Bank of Korea. This brings its total investments since its founding in 2016 to 50...
Two radiologists analysing a brain scan
By  Adam Ang 02:46 am December 16, 2022
Indian AI imaging company In-Med Prognostics has received $2.13 million in investment from Exxora and other angel investors.  WHAT IT DOES Established in 2018, the company leverages deep learning and machine learning algorithms to generate brain scan analyses to aid the assessment and early detection of neurological disorders, including dementia, Alzheimer's disease, and Parkinson's disease. It...